Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2001-07-16 | Eurelio M. Cavalier has served on our Board of Directors since September 1998. |
| 2002-07-15 | Eurelio M. Cavalier has served on the Board of Directors since September 1998. He is a member of the Executive Committee. |
| 2003-07-14 | During the year ended December 31, 2002, the members of our Compensation Committee of the Board of Directors were Dr. Ernst-Gunter Afting, Mr. Eurelio M. Cavalier, Dr. Hubert E. Huckel and Dr. Konrad M. Weis. |
| 2004-08-11 | Eurelio M. Cavalier has served on our Board of Directors since September 1998. |
| 2005-07-12 | Eurelio M. Cavalier has served on our Board of Directors since September 1998. |
| 2006-08-10 | Eurelio M. Cavalier has served on our Board of Directors since September 1998. He was employed in various capacities by Eli Lilly & Co. from 1958 until his retirement in 1994, serving as Vice President Sales from 1976 to 1982 and Group Vice President U.S. Pharmaceutical Business Unit from 1982 to 1993. |
| 2007-08-15 | Eurelio M. Cavalier has served on our Board of Directors since September 1998. The Board of Directors has an Executive Committee, a Compensation Committee, a Nominating Committee and an Audit Committee. The Compensation Committee consists of three directors, Eurelio M. Cavalier, Hubert E. Huckel and Konrad M. Weis. The Nominating Committee consists of three directors, Eurelio M. Cavalier, M. David MacFarlane and Ley S. Smith. |
| 2008-04-03 | Eurelio M. Cavalier has served on our Board of Directors since September 1998. He was employed in various capacities by Eli Lilly & Co. from 1958 until his retirement in 1994, serving as Vice President Sales from 1976 to 1982 and Group Vice President U.S. Pharmaceutical Business Unit from 1982 to 1993. ... Member of Executive Committee ... Member of Compensation Committee ... Member of Nominating Committee ... Non-employee directors are entitled to receive a fee for each meeting attended ... During 2007, each director was granted an annual option to purchase 5,000 shares ... In addition to having their out-of-pocket expenses reimbursed, non-employee directors received $2,500 for each Board of Directors meeting attended in 2007. ... Eurelio M. Cavalier Fees Earned or Paid in Cash($): 15,000 ... Total: 35,817 |
| 2015-07-20 | Eurelio M. Cavalier was employed in various capacities by Eli Lilly & Co. from 1958 until his retirement in 1994, serving as Vice President Sales from 1976 to 1982 and Group Vice President U.S. Pharmaceutical Business Unit from 1982 to 1993. Based on Mr. Cavalier's management experience in the pharmaceutical industry, particularly in the area of sales and marketing, our Board believes that Mr. Cavalier has the appropriate set of skills to serve as a member of the Board. |
| 2016-06-29 | The compensation committee currently consists of Joseph A. Akers, Victor J. Bauer and Eurelio M. Cavalier, each of whom meets the independence requirements and standards currently established by Nasdaq. The purpose of the governance committee is to assist the Board in identifying qualified individuals to become board members, in determining the composition of the Board and in monitoring the process to assess Board effectiveness. The governance committee currently consists of Eurelio M. Cavalier and James R. McNab, Jr., each of whom meets the independence requirements and standards currently established by the Nasdaq. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22